- It is a generic version of Pfizer’s COVID-19 oral drug Paxlovid.
- Pfizer’s Paxlovid got approval from the US Food and Drug Administration (FDA), in 2021.
- The generic version, Paxgen, will contain a combination of two tablets, namely, Nirmatrelvir and Ritonavir.
- The combination of these tablets will assist patients with mild to moderate symptoms of COVID-19.
- A box of Paxzen will contain 20 tablets of Nirmatrelvir 150mg and 10 tablets of Ritonavir 100mg and the Maximum Retail Price (MRP) will be Rs. 5200 per box.
- Zenara Pharma is a fully-owned subsidiary of Hyderabad-based Biophore India Pharmaceuticals and was incorporated in 2004. The Co-founder and Managing Director of Zenara Pharma are Jagadeesh Babu Rangisetty.
Question:
Q.1 The oral tablet for COVID19, Paxgen, will be manufactured by?a. Serum Institute of India
b. Bharat Biotech
c. Zenara Pharma
d. Moderna
